BMY Stock Dips Despite Broader Market Stability; Analysts Forecast EPS Decline But Revenue Growth
• Bristol Myers Squibb (BMY) stock closed down 0.3% despite broader market only falling 0.29-0.35%
• BMY shares have gained 7.69% over the past month compared to 4.42% for the S&P 500
• Analysts estimate BMY will report earnings per share of $1.53 for Q1 2024, a 25.37% year-over-year decline
• For full fiscal year 2024, projections call for EPS of $6.61, down 11.98%, and revenue of $46.11 billion, up 2.44%
• BMY currently has a Zacks Rank of #4 (Sell), but over the past 30 days EPS estimates have moved 1.29% higher